SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-027685
Filing Date
2023-05-05
Accepted
2023-05-05 16:35:30
Documents
1
Period of Report
2023-05-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4990
  Complete submission text file 0001209191-23-027685.txt   7109
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Issuer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4747 EXECUTIVE DRIVE, SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE, SUITE 210 SAN DIEGO CA 92121 8582003830
Concentra Biosciences, LLC (Reporting) CIK: 0001970065 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37998 | Film No.: 23894462

Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 (858) 200-3830
Concentra Merger Sub, Inc. (Reporting) CIK: 0001972123 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37998 | Film No.: 23894461